The research pipeline

OB/GYN News, Nov 15, 2005 by Mary Ellen Schneider

Drug researchers are currently developing 446 medicines aimed at the diseases that disproportionately affect women in the United States, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). These medicines are either in clinical trails or awaiting approval by the Food and Drug Administration.

The bulk of the drugs are for the treatment of cancer, including 62 for breast cancer, 38 for ovarian cancer, and 13 for cervical cancer. Fifty-eight medicines are being developed to treat obstetric and gynecologic conditions, according to PhRMA.

COPYRIGHT 2005 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale